bumetanide has been researched along with Lung Neoplasms in 4 studies
Lung Neoplasms: Tumors or cancer of the LUNG.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We explored if the K(+) efflux stimulator amphotericin B, with or without the Na(+), K(+), 2Cl(-)-cotransport (K(+) influx) blocker bumetanide, could affect cisplatin- and carboplatin-induced apoptosis and cytotoxicity in the pulmonary mesothelioma cell line (P31)." | 7.71 | Cisplatin-induced apoptosis of mesothelioma cells is affected by potassium ion flux modulator amphotericin B and bumetanide. ( Grankvist, K; Henriksson, R; Marklund, L, 2001) |
| "We used 86Rb+ (K+ analogue) to study potassium influx during the interaction of highly specific 5-HT3-receptor antagonists, ondansetron and granisetron, with the effects of the anticancer drug, estramustine phosphate, on P31 mesothelioma cells." | 3.71 | Diverging effects of 5-HT3 receptor antagonists ondansetron and granisetron on estramustine-inhibited cellular potassium transport. ( Behnam-Motlagh, P; Grankvist, K; Henriksson, R; Sandström, PE, 2001) |
| " We explored if the K(+) efflux stimulator amphotericin B, with or without the Na(+), K(+), 2Cl(-)-cotransport (K(+) influx) blocker bumetanide, could affect cisplatin- and carboplatin-induced apoptosis and cytotoxicity in the pulmonary mesothelioma cell line (P31)." | 3.71 | Cisplatin-induced apoptosis of mesothelioma cells is affected by potassium ion flux modulator amphotericin B and bumetanide. ( Grankvist, K; Henriksson, R; Marklund, L, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shen, BQ | 1 |
| Finkbeiner, WE | 1 |
| Wine, JJ | 1 |
| Mrsny, RJ | 1 |
| Widdicombe, JH | 1 |
| Sandström, PE | 2 |
| Jonsson, O | 1 |
| Grankvist, K | 3 |
| Henriksson, R | 3 |
| Behnam-Motlagh, P | 1 |
| Marklund, L | 1 |
4 other studies available for bumetanide and Lung Neoplasms
| Article | Year |
|---|---|
Calu-3: a human airway epithelial cell line that shows cAMP-dependent Cl- secretion.
Topics: Bradykinin; Bumetanide; Calcimycin; Cell Line; Cell Membrane; Cell Membrane Permeability; Chloride C | 1994 |
Identification of potassium flux pathways and their role in the cytotoxicity of estramustine in human malignant glioma, prostatic carcinoma and pulmonary carcinoma cell lines.
Topics: Bumetanide; Cell Division; Estramustine; Furosemide; Glioma; Humans; Ion Transport; Lung Neoplasms; | 1994 |
Diverging effects of 5-HT3 receptor antagonists ondansetron and granisetron on estramustine-inhibited cellular potassium transport.
Topics: Antiemetics; Antineoplastic Agents; Biological Transport; Bumetanide; Chlorides; Drug Interactions; | 2001 |
Cisplatin-induced apoptosis of mesothelioma cells is affected by potassium ion flux modulator amphotericin B and bumetanide.
Topics: Amphotericin B; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bu | 2001 |